Expands existing claims to include any omega-3 phospholipid containing at least 50% phospholipids LAVAL, Québec, April 20, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 […]
Other News
ImpediMed Releases Most Comprehensive Software Package for SOZO® Digital Health Platform
Bioimpedance Spectroscopy Technology Used by Hospitals and Large Oncology Groups as Part of Lymphedema Prevention Program Adds Heart Failure and Renal Disease Capabilities CARLSBAD, Calif., April 20, 2020 /PRNewswire/ — ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS), today […]
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology
REHOVOT, Israel, April 20, 2020 /PRNewswire/ — Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a $27 million round of financing, led by Sofinnova Partners, a leading European life sciences venture capital firm, and joined by Professor Jacques Séguin, Chairman of the […]
Michael Coyle Joins Haemonetics Board of Directors
BOSTON, April 17, 2020 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced the election of Michael Coyle to its Board of Directors. Coyle serves as the Executive Vice President and Group President, Cardiac and Vascular Group for Medtronic where he oversees […]
VALBIOTIS Accelerates Its Pipeline Clinical Development in New Indications: Cardiovascular and Hepatic Steatosis Risk Reduction
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/ SME eligible), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the acceleration of its pipeline clinical development, of plant-derived active substances, in new indications: cardiovascular and hepatic steatosis risk. Building […]
Cardiac Insight Launches New Telehealth Solution for Cardiology Practices with Heart@Home™ ECG Test Kit
Direct-to-patient Cardea SOLO™ wearable ECG speeds clinical decision-making while removing costly and time-consuming outsourcing of data analysis Bellevue, WA, April 16, 2020 (GLOBE NEWSWIRE) — Cardiac Insight, Inc., a US-based digital healthcare innovator specializing in body-worn sensor technology and automated electrocardiogram (ECG)-analysis software, announces the Heart@Home™ ECG Test Kit to address new telehealth […]
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019
WINNIPEG, April 15, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter and year ended December 31, 2019. Year Ended December 31, 2019 Highlights: Recorded total net revenue from the sale of products of $20.2 million during the year ended December 31, 2019 compared to $29.1 million for […]
Proximo Medical Named Commercialization Partner for Elucid Bioimaging
CASTLE PINES, Colo., April 16, 2020 /PRNewswire/ — Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Elucid Bioimaging, a developer of diagnostic image analysis software used to assist in the detection and treatment […]
ABBOTT REPORTS FIRST-QUARTER 2020 RESULTS
– First-quarter sales growth of 2.5 percent; organic sales growth of 4.3 percent – Recently launched three breakthrough diagnostics tests for coronavirus (COVID-19) ABBOTT PARK, Ill., April 16, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2020. First-quarter worldwide sales of $7.7 billion increased 2.5 percent on […]
Endologix Appoints Tim A. Benner as Chief Commercial Officer
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Tim A. Benner to succeed John Zehren as the Company’s Chief Commercial Officer, effective as of April 14, 2020. Mr. Benner brings to Endologix […]



